Skip to Main Content
header search
Search
Skip Nav Destination

Issues

Volume 13, Issue 5
October 2023
Issue Cover
eISSN 2168-9709
In this Issue

ORIGINAL RESEARCH

Barriers to access to psychiatric medications in Missouri county jails
Jessica K. Burval, PharmD, BCPP; Courtney A. Iuppa, PharmD, BCPP; Carrie R. Kriz, MS; Shelby E. Lang, PharmD, BCPP; Leigh Anne Nelson, PharmD, BCPP; Nicole A. Gramlich, PharmD, BCPP; Ellie S. R. Elliott, PharmD, BCPP; Roger W. Sommi, PharmD, BCCP, FCCP
View Articletitled, Barriers to access to psychiatric medications in Missouri county jails
Open the PDF for in another window
Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
Daniel O. Claassen, MD; Rajeev Ayyagari, PhD; Viviana García-Horton, PhD; Su Zhang, PhD; Sam Leo, PharmD
View Articletitled, Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
Open the PDF for in another window
Consumer perception, knowledge, and uses of cannabidiol
Cambrey Nguyen, PharmD; Karen E. Moeller, PharmD; Michael McGuire, PharmD; Brittany L. Melton, PharmD, PhD
View Articletitled, Consumer perception, knowledge, and uses of cannabidiol
Open the PDF for in another window
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
Jonathan M. Meyer, MD; Craig Chepke, MD; Rimal B. Bera, MD; M. Mercedes Pérez-Rodríguez, MD, PhD; Leslie Lundt, MD; Ericha G. Franey, PhD; Rahul Dhanda, PhD, MA; Betsy Benning, MBA; Morgan Bron, PharmD, MS; Chuck Yonan, PharmD
View Articletitled, Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
Open the PDF for in another window
Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
Mohammad Adam Hamad, PharmD, BCPS; Andrew Williams, PharmD, BCPP; Jamie Kneebusch, PharmD, BCPS, BCPP; Niyati Butala, PharmD, BCPP
View Articletitled, Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
Open the PDF for in another window

CASE REPORT

Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
Kaitlyn Baldwin, PharmD; Annabelle Wanson, MD, FRCPC; Lee-Anne Gilecki, MD, FRCPC; Courtney Dalton, BSP; Evyn Peters, MD, FRCPC; Katelyn Halpape, BSP, ACPR, PharmD, BCPP
View Articletitled, Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
Open the PDF for in another window

REVIEW OF DRUGS/PHARMACOTHERAPY

Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports
Alejandro Del Rio Verduzco, PharmD, MS; Ahva Salari, BS; Parna Haghparast, PharmD, BCPS
View Articletitled, Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports
Open the PDF for in another window
All Issues
  • eISSN 2168-9709
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept